Academic Journal

A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study

التفاصيل البيبلوغرافية
العنوان: A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study
المؤلفون: Yamada, Tadaaki, Goto, Yasuhiro, Tanaka, Hiroshi, Kimura, Hideharu, Minato, Koichi, Gyotoku, Hiroshi, Honda, Takeshi, Watanabe, Satoshi, Morimoto, Kenji, Kiyomi, Fumiaki, Uchino, Junji, Takayama, Koichi
المساهمون: AstraZeneca KK, AstraZeneca
المصدر: European Journal of Cancer ; volume 195, page 113373 ; ISSN 0959-8049
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.ejca.2023.113373
الاتاحة: http://dx.doi.org/10.1016/j.ejca.2023.113373
https://api.elsevier.com/content/article/PII:S0959804923006755?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0959804923006755?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.9F060AAD
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.ejca.2023.113373